Cite
Impact of Pretransplantation 18F-fluorodeoxy Glucose–Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.
MLA
Bachanova, Veronika, et al. “Impact of Pretransplantation 18F-Fluorodeoxy Glucose–Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.” Biology of Blood & Marrow Transplantation, vol. 21, no. 9, Sept. 2015, pp. 1605–11. EBSCOhost, https://doi.org/10.1016/j.bbmt.2015.05.007.
APA
Bachanova, V., Burns, L. J., Ahn, K. W., Laport, G. G., Akpek, G., Kharfan-Dabaja, M. A., Nishihori, T., Agura, E., Armand, P., Jaglowski, S. M., Cairo, M. S., Cashen, A. F., Cohen, J. B., D’Souza, A., Freytes, C. O., Gale, R. P., Ganguly, S., Ghosh, N., Holmberg, L. A., & Inwards, D. J. (2015). Impact of Pretransplantation 18F-fluorodeoxy Glucose–Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma. Biology of Blood & Marrow Transplantation, 21(9), 1605–1611. https://doi.org/10.1016/j.bbmt.2015.05.007
Chicago
Bachanova, Veronika, Linda J. Burns, Kwang Woo Ahn, Ginna G. Laport, Görgün Akpek, Mohamed A. Kharfan-Dabaja, Taiga Nishihori, et al. 2015. “Impact of Pretransplantation 18F-Fluorodeoxy Glucose–Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.” Biology of Blood & Marrow Transplantation 21 (9): 1605–11. doi:10.1016/j.bbmt.2015.05.007.